Chief Physician Hematology, 80-100 %
- Employment type
- Full-time
- Workload
- 80–100%
- Location
- Zürich
- Languages
- German, German
- First posted
Shape the future of hematology at Stadtspital Zürich
Hematology and Medical Oncology have developed into independent, highly specialized disciplines in recent years. To meet this development as well as the increasing requirements for patient care, research and teaching, the two departments at Stadtspital Zürich will in the future be led by their own respective chief physician management.
For this demanding key position, we are looking for an entrepreneurially minded and visionary leadership personality. In this function, you will be responsible for and shape the strategic, professional and cross-site development of hematology at Stadtspital Zürich and, together with the chief physician management of Medical Oncology, shape the future of a modern, university-level cancer medicine.
Tasks
- Professional, strategic and personnel leadership of hematology at a center hospital with several locations
- Further development of hematology with a special focus on malignant hematology, cellular therapies and innovative treatment methods
- Ensuring high-quality care for patients across the entire spectrum of benign and malignant hematology as well as coagulation medicine
- Responsibility for the further development of cooperation with Universitätsspital Zürich, particularly in the area of immunological and cellular therapies as well as stem cell transplantations
- Design and maintenance of the interface between the clinic and hematological laboratory diagnostics in close cooperation with the responsible institutes and departments
- Partnership-based and equal cooperation with the Chief Physician Medical Oncology on strategic, organizational and medical issues
- Participation in research, teaching and the positioning of Stadtspital Zürich as a leading hematological competence center
Profile
- Specialist title Hematology (FMH); FAMH title or corresponding experience in the laboratory environment is an advantage
- Proven expertise in malignant hematology with focal competence in the area of cellular therapies; experience in the environment of stem cell transplantations
- Sound understanding of the requirements for modern hematological diagnostics as well as the interface between clinic and laboratory
- Several years of leadership and management experience at executive level in a university or center hospital; leadership training is an advantage
- Experience in cooperation with university centers and interdisciplinary networks as well as in complex clinical cooperation models
- Strong social competence, negotiation skills and the ability for collegial and consensus-oriented leadership in the two-chief-physician model
- Scientific profile with commitment to research and teaching; habilitation is an advantage, but not a requirement
We offer
We offer you a demanding key position with great creative freedom in a dynamic center hospital. Together with the Chief Physician Medical Oncology and a dedicated interprofessional team, you will shape the future direction of hematology and make a significant contribution to the further development of a modern, networked and university-level cancer medicine at Stadtspital Zürich.
About us
As a center hospital with specialized and highly specialized service mandates, Stadtspital Zürich pursues the goal of developing hematology at the highest clinical level. In addition to malignant hematology, the field also includes benign hematology, coagulation medicine and close cooperation with hematological laboratory diagnostics. In particular, the rapid development of innovative treatment methods, such as immunological and cellular therapies, requires strong professional leadership and close networking with university partners.
Interested?
For further information, Prof. Dr. med. Andreas Schoenenberger, Head of Department Internal Medicine, +41 44 416 30 03, is at your disposal.
Reference No.: 52049
More about the employer Stadt Zürich
Automatically translated from the original.
Posted yesterday